- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07943442
Novel MRI for an Earlier Diagnosis of Motor Neurone Disease (MRF MND)
The goal of the study is Can MR Fingerprinting identify quantitative differences in brains of patients with MND and age-matched healthy controls?
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The Investigators will recruit consecutive patients with MND, identified via the Leeds MND clinic.
Patients will be provided with a patient information sheet (PIS) when they attend the clinic and will have the opportunity to discuss the study with a clinician and ask questions.
If they are willing and able to provide informed consent at this time, consent will be taken, and the participant will be reassured they may withdraw at any time. If the patient wishes time to consider the study, with their permission, they will be contacted via telephone after 24 hours and asked whether or not they wish to be included, again reassured they may withdraw at any time.
An email inviting individuals aged 18 or over to undergo MR imaging of the brain will be distributed throughout Leeds Teaching Hospitals Trust. Those interested will be asked to send their contact details via e-mail reply to the Department of Neuroradiology.
Potential participants will be contacted by a member of the research team and will be taken through a pre-prepared questionnaire detailing present and past medical history. Individuals that answer negatively for the presence of chronic or current illness, particularly regarding neurological disease or psychiatric conditions and that are free from medication and that satisfy MR safety regulations (i.e. no cardiac pacemakers or metallic implants) will be provided with an MRI appointment. All participants will be sent (via email and at least 24 hours prior to the MRI appointment) a PIS. Informed consent will be obtained on arrival for their MRI appointment by a member of the research team.
A consultant neuroradiologist will review all imaging for both cohorts. Any incidental pathology discovered on the MRI requiring medical review will be recorded as a 'Foreign Films for Opinion' on the the Leeds Teaching Hospitals Trust radiology information system and will be alerted to the volunteers' GP, reflecting pre-existing practice within Leeds Teaching Hospitals Trust for research imaging studies.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Stuart Currie
- Numéro de téléphone: +44 01133923180
- E-mail: stuartcurrie@nhs.net
Lieux d'étude
-
-
West Yorkshire
-
Leeds, West Yorkshire, Royaume-Uni, LS9 7TF
- Recrutement
- Leeds Teaching Hospitals NHS Trust
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
The target population will be patients with MND attending the MND clinic, Leeds Teaching Hospitals Trust and healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust.
Although MND (ALS) can strike at any age, symptoms most commonly develop between the ages of 55 and 75. Men are slightly more likely to develop ALS than women. However, at older ages, men and women are equally likely to be diagnosed with ALS. Whites and non-Hispanics are most likely to develop the disease, but ALS affects people of all races and ethnic backgrounds.
La description
Inclusion criteria all participants:
- ≥18yrs
- Able and willing to provide consent
- Able to communicate with staff and safely comply with the study procedures
Additional inclusion criteria for MND participants:
- ALS patients with definite or probable motor neuron disease based on the Awaji criteria
Additional inclusion criteria for healthy volunteers:
- Free from chronic or current illness particularly:
- Neurological disorders including migraines
- Psychiatric disorders
- Prior head injury resulting in brain damage
- Prior neurosurgical or neurovascular intervention
- Free from taking medication
- Non-drug and non-alcohol abuse
- Non-smoker
Exclusion criteria all participants:
-
Contraindication to MRI, including:
- non-MRI compatible medical devices and implants
- in patients with previous penetrating trauma to the eye, or patients at high risk of previous metal foreign body injury to the eye (e.g. welding), skull x-ray will be performed; these patients may be included in the absence of residual metal fragments on x-ray
- Inability to lie flat in the MRI scanner
- ALS patients in an advanced disease stage (ALSFRS-R < 25) with respiratory insufficiency (forced vital capacity (FVC) < 60%), on non-invasive ventilation or receiving percutaneous gastrostomy feeding.
-
Pregnant
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_CONTROL
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
MND Patients
MND |
MRI of the brain including MRF |
|
Healthy Volunteers
Healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust |
MRI of the brain including MRF |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quantitative values of brain cortical regions on MRF
Délai: Scan time of less than 60 minutes
|
Both cohorts will undergo the same MRI protocol comprising routine clinical structural imaging of the brain and MRF; with a scan time of less than 60 minutes. All images from both cohorts will be reviewed by a consultant neuroradiologist. Should there be any unexpected findings, the volunteers' GP will be informed in writing. After the scan, the volunteers from both cohorts will be free to leave, at which point their direct participation in the study will concluded. |
Scan time of less than 60 minutes
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies du système nerveux central
- Maladies du système nerveux
- Maladies neuromusculaires
- Maladies métaboliques
- Maladies neurodégénératives
- Maladies de la moelle épinière
- TDP-43 Protéinopathies
- Déficits de protéostase
- Maladie du motoneurone
- Maladies nutritionnelles et métaboliques
- La sclérose latérale amyotrophique
Autres numéros d'identification d'étude
- NE25/181701
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .